Cardiac management of ventilator-assisted individuals with duchenne muscular dystrophy

Chronic Respiratory Disease

Volumn 11, Issue 2, 2014, Pages 103-110

  O'Brien, Lauren ^a,b   Varadi, Robert ^a,b   Goldstein, Roger S ^a,b   Evans, Rachael A ^a,b,c,d  

^a WEST PARK HEALTHCARE CENTRE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

cardiomyopathy; Duchenne muscular dystrophy; noninvasive ventilation; respiratory failure; ventilator assisted

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DEFLAZACORT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE; DIURETIC AGENT;

ADULT; ARTICLE; ASSISTED VENTILATION; CARDIOLOGIST; CARDIOLOGY; CARDIOMYOPATHY; CARDIOPULMONARY FUNCTION; CLINICAL ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; MALE; MEDICAL AUDIT; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIORITY JOURNAL; Q WAVE; R WAVE; SINUS TACHYCARDIA; VENTILATED PATIENT; ARTIFICIAL VENTILATION; CARDIOMYOPATHIES; COMPLICATION; DIAGNOSIS; DRUG THERAPY; ELECTROCARDIOGRAPHY; ETIOLOGY; MUSCULAR DYSTROPHY, DUCHENNE; PATIENT ATTITUDE; PRACTICE GUIDELINE; UTILIZATION; YOUNG ADULT;

ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOMYOPATHIES; DIURETICS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MEDICAL AUDIT; MUSCULAR DYSTROPHY, DUCHENNE; PATIENT ACCEPTANCE OF HEALTH CARE; PRACTICE GUIDELINES AS TOPIC; RESPIRATION, ARTIFICIAL; SPIRONOLACTONE; VENTRICULAR DYSFUNCTION, LEFT; YOUNG ADULT;

EID: 84899017543     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314529673     Document Type: Article

References (30)

1. Emery AEH. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscular Disord. 1991 ; 1 (1). 19-29
2. Lapidos KA, Kakkar R, McNally EM. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res. 2004 ; 94 (8). 1023-1031
3. Emery AE. The muscular dystrophies. Lancet. 2002 ; 359 (9307). 687-695
4. Rahbek J, Werge B, Madsen A, et al. Adult life with Duchenne muscular dystrophy: observations among an emerging and unforeseen patient population. Pediatr Rehabil. 2005 ; 8 (1). 17-28
5. Eagle M, Baudouin SV, Chandler C, et al. Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscular Disord. 2002 ; 12 (10). 926-929
6. Jeppesen J, Green A, Steffensen BF, et al. The Duchenne muscular dystrophy population in Denmark, 1977-2001: prevalence, incidence and survival in relation to the introduction of ventilator use. Neuromuscular Disord. 2003 ; 13 (10). 804-812
7. Nigro G, Comi LI, Politano L, et al. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol. 1990 ; 26 (3). 271-277
8. Spurney CF. Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions. Muscle Nerve. 2011 ; 44 (1). 8-19
9. Hermans MCE, Pinto YM, Merkies ISJ, et al. Hereditary muscular dystrophies and the heart. Neuromuscular Disord. 2010 ; 20 (8). 479-492
10. Viollet L, Thrush PT, Flanigan KM, et al. Effects of angiotensin- converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol. 2012 ; 110 (1). 98-102
11. Connuck DM, Sleeper LA, Colan SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the pediatric cardiomyopathy registry. Am Heart J. 2008 ; 155 (6). 998-1005
12. Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J. 2007 ; 154 (3). 596-602
13. Ogata H, Ishikawa Y, Ishikawa Y, et al. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol. 2009 ; 53 (1). 72-78
14. Duboc D, Meune C, Lerebours G, et al. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol. 2005 ; 45 (6). 855-857
15. Bushby K, Finkel R, Birnkrant D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010 ; 9 (2). 177-189
16. Bushby K. Muntoni F and Bourke JP. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002. Naarden, the Netherlands. Neuromuscular Disord. 2003 ; 13 (2). 166-172
17. Kwon SW, Kang SW, Kim JY, et al. Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital. Cardiology. 2012 ; 121 (3). 186-193
18. Bushby K, Finkel R, Birnkrant D, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010 ; 9 (1). 77-93
19. Hunt S, Abraham W, Chin M, et al. Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/American heart association task force on practice guidelines: developed in collaboration with the international society for heart and lung transplantation. Circulation. 2009 ; 119 (14). e391 - e479
20. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr. 2005 ; 18 (12). 1440-1463
21. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American society of echocardiography endorsed by the European association of echocardiography, a registered branch of the European society of cardiology, and the Canadian society of echocardiography. J Am Soc Echocardiogr. 2010 ; 23 (7). 685-713
22. Sasaki K, Sakata K, Kachi E, et al. Sequential changes in cardiac structure and function in patients with Duchenne type muscular dystrophy: a two-dimensional echocardiographic study. Am Heart J. 1998 ; 135 (6). 937-944
23. American Academy of Pediatrics Section on Cardiology, Cardiac, Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics. 2005 ; 116 (6). 1569-1573
24. Melacini P, Vianello A, Villanova C, et al. Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy. Neuromuscular Disord. 1996 ; 6 (5). 367-376
25. Schram G, Fournier A, Leduc H, et al. All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol. 2013 ; 61 (9). 948-954
26. Hor KN, Wansapura J, Markham LW, et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol. 2009 ; 53 (14). 1204-1210
27. Hor KN, Taylor MD, Al-Khalidi HR, et al. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson. 2013 ; 107: 15
28. Hagenbuch SC, Gottliebson WM, Wansapura J, et al. Detection of progressive cardiac dysfunction by serial evaluation of circumferential strain in patients with Duchenne muscular dystrophy. Am J Cardiol. 2010 ; 105 (10). 1451-1455
29. Mazur W, Hor KN, Germann JT, et al. Patterns of left ventricular remodeling in patients with Duchenne muscular dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. Int J Cardiovasc Imaging. 2012 ; 28 (1). 99-107
30. van Bockel EA, Lind JS, Zijlstra JG, et al. Cardiac assessment of patients with late stage Duchenne muscular dystrophy. Neth Heart J. 2009 ; 17 (6). 232-237